Pennsylvania · Nonprofit
Fox Chase Cancer Center Medical GroupIn
Fox Chase Cancer Center Medical GroupIn (Pennsylvania) receives grants from 21 organizations whose IRS filings report $686,763 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($182,525). 9 of them have funded it in more than one year, and 69% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2025
- $116M
- Funders on record
- 21
- Grants received
- $687k
- Net assets
- $2.2M
What Fox Chase Cancer Center Medical GroupIn does
Mission
To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention and compassionate care.
As stated on its FY2025 Form 990.
Programs
Medical oncology - the medical oncology department provides quality diagnosis, treatment, and care for patients with cancer. Traditional chemotherapy and new clinical trials provide our medical oncologists with access to a tremendous range of new anticancer treatments, including medicines and combinations of medicines that can be delivered to cancer patients.
$22,601,473 spent$13,050,316 earned by the program21% of program spendingSurgical oncology - the department of surgery provides comprehensive surgical treatment, and supporting anesthesiology services, to patients with malignant diseases of the breast, gastrointestinal tract, liver, reproductive organs, and other disease sites.
$20,539,218 spent$11,859,550 earned by the program19% of program spendingMedicine - the physicians in the department of medicine treat other medical issues as well as cancer related illnesses. It is believed that in treating the whole person, our cancer patients experience continuity of care and ultimately better outcomes. The department of internal medicine includes physicians specializing in gastroenterology, dermatology, internal medicine, psychiatry, endocrinology, physical medicine and pulmonary. In addition fox chase provides services for infectious diseases, cardiology, and nephrology. These physicians deliver quality care for cancer and non-cancer patients, providing medical management of existing diseases, prevention screenings, fine needle biopsies, and diagnostic and endoscopic procedures.
$18,961,059 spent$10,948,305 earned by the program18% of program spendingRadiation Oncology - The primary goal of the Radiation Oncology department is to develop and implement treatment programs geared towards maximizing the chances of curing cancer while minimizing the radiation dose to normal organs, thus attempting to maintain quality of life and preserve normal organ function. Patients are evaluated for the most effective treatment by a team of experienced radiation oncologists, radiation physicists, certified therapists and dosimetrists, and specialized radiation oncology nurses.
$15,299,707 spent$8,834,204 earned by the program14% of program spendingRadiology - The department of Radiology offers the most advanced technologies for cancer imaging, staging (determining the extent of the cancer), and cancer treatment planning. Diagnostic imaging services include mammography, CT, ultrasound, nuclear medicine, PET/CT, MRI, Fluoroscopy and CT Colonography. Review and consultation services are also available at Fox Chase for films submitted by other physicians.
$9,564,501 spent$5,522,638 earned by the program9% of program spendingPathology - The diagnostic services of the department of pathology consist of surgical pathology, immunohistochemistry, flow cytometry, hematopathology, clinical pathology, and autopsy pathology. An important part of the pathology program is the training of residents and fellows. Members of the department are active participants in collaborative research.
$7,482,770 spent$4,320,626 earned by the program7% of program spendingClinical Genetics - The department of Clinical Genetics provides risk assessment services to those at high risk for all types of cancer. A combination of family history and genetic data is used to build a profile of risk for all cancer types including but not limited to breast, ovarian, gastrointestinal, prostrate, thyroid, and melanoma.
$1,063,373 spent$614,002 earned by the program1% of program spendingAll Other Program Services
$12,808,374 spent$60,339,742 earned by the program12% of program spending
The 8 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $108,320,475.
The organization over time
Each line starts at 100 in 2020, so what you read is the shape rather than the size: 150 means half as much again as 2020, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2024 to 2025, from $45M to $59M (+31%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2020 1% · 2021 3% · 2023 0%. Grants only. Government contracts and fees sit inside program revenue.
1% of Fox Chase Cancer Center Medical GroupIn’s revenue is contributions — about as donation-reliant as the typical peer (1% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 6 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Dr Robert Uzzo
President & CEO
As listed on its FY2025 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 1 funder to 9 funders, grant income rose $250 → $153k.
7 of 21 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 69% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $84M from 2 payers (the payer shares this organization's board, largest The American Oncologic Hospital). These are real filings, and they are not money Fox Chase Cancer Center Medical GroupIn raised.
From the IRS filings of Fox Chase Cancer Center Medical GroupIn’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
Fox Chase Cancer Center Medical GroupIn has a broad base — no single funder exceeds 27% of grant income, and it takes 3 funders to reach half.
the vertical line marks half of all grant income — 3 funders to its left
97% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund Fox Chase Cancer Center Medical GroupIn.
Largest funder’s share by year: 2017 100% · 2018 100% · 2019 48% · 2020 80% · 2021 49% · 2022 25% · 2023 34% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
20% of Fox Chase Cancer Center Medical GroupIn's funders are still giving 3 years after their first grant; 43% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
69% of Fox Chase Cancer Center Medical GroupIn's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $212k that is directly attributable, 66% of it comes from funders outside Pennsylvania, across 9 states.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $474k arriving through sponsors registered in 6 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
Fox Chase Cancer Center Medical GroupIn has grown faster than half of the 1,256 health nonprofits its size.
this organization peer median middle 50% of peers· 1,256 health nonprofits over $100M, FY2025
Organizations like Fox Chase Cancer Center Medical GroupIn
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Pennsylvania
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
94% of spending goes to programs.
Governance
Footprint & structure
Files a return copy in 1 state
Part of a family of 16 related entities
- Temple University of the Commonwealth System of Higher Ed · exempt
- Temple University Health System Inc · exempt
- Temple University Hospital · exempt
- Temple Physicians Inc · exempt
- Temple Health Transport Team Inc · exempt
Screen this organization
A dated, signed PDF of the compliance screen for Fox Chase Cancer Center Medical GroupIn: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds Fox Chase Cancer Center Medical GroupIn?
- Fox Chase Cancer Center Medical GroupIn (Pennsylvania) receives grants from 21 organizations whose IRS filings report $686,763 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($182,525). 9 of them have funded it in more than one year, and 69% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does Fox Chase Cancer Center Medical GroupIn have?
- IRS filings report 21 organizations giving $686,763 in grants to Fox Chase Cancer Center Medical GroupIn, 9 of which have funded it in more than one year.
- Who is the largest funder of Fox Chase Cancer Center Medical GroupIn?
- FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $182,525 in grants. The full list of funders is on this page.
- How can an organization like Fox Chase Cancer Center Medical GroupIn find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Pennsylvania. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Fox Chase Cancer Center Medical GroupIn →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2020–2025), and the filings of 21 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing